CTKB vs UNH · rev $92.3M vs P/E 30, rev $112.03B
Cytek Biosciences Inc (CTKB) versus UnitedHealth Group Incorporated (UNH) — a side-by-side from cached financials, not a winner call.
Cytek Biosciences Inc (CTKB) is a medical devices company listed on US.
UnitedHealth Group Incorporated (UNH) is a healthcare plans company listed on NYSE. It is led by Stephen J. Hemsley.
Latest reported CTKB revenue for 2026-06-30 was $92.3M. Net income was -$31.0M. CTKB currently screens at market cap $421.8M.
Latest reported UNH revenue for 2026-06-30 was $112.03B. Net income was $5.48B. Revenue was up 0.3% from 2026-03-31 to 2026-06-30. UNH currently screens at market cap $362.83B and trailing P/E 30.1.
CTKB currently screens at market cap $421.8M. UNH currently screens at market cap $362.83B and trailing P/E 30.1.
Not investment advice. Open the CTKB and UNH stock pages for the full models.
Not investment advice.